Hirokazu Taniguchi

21PUBLICATIONS
85CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersAutoimmunityMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 29, 2026
Immunotherapy and the novel therapeutic development for small-cell lung cancer.

|Oct 29, 2025
A phase II clinical trial on the efficacy and safety of carboplatin plus nab-paclitaxel in chemotherapy-naive advanced or recurrent thymic epithelial tumors: protocol of Nab-TET.

Fumiko Hayashi, Midori Matsuo, Shinnosuke Takemoto

|Jul 10, 2025
Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1-Expressing Non-Small Cell Lung Cancer.

Tae Hata, Tadaaki Yamada, Yasuhiro Goto

|May 19, 2025
Impact of immune-related adverse events on clinical outcomes in patients with advanced non-small cell lung cancer with low PD-L1 expression, focusing on pneumonitis: a multicenter retrospective study in Japan.

Shiho Goda, Tadaaki Yamada, Kenji Morimoto

|Apr 03, 2025
Immunoglobulin G4-Related Disease of the Sternoclavicular Joint: A Case Report.

Remi Mizuta, Shinnosuke Takemoto, Mutsumi Ozasa

|Mar 31, 2025
Randomized Phase III Study of EGFR Tyrosine Kinase Inhibitor and Intercalated Platinum-Doublet Chemotherapy for Non-Small Cell Lung Cancer Harboring EGFR Mutation.

Shintaro Kanda, Seiji Niho, Takayasu Kurata

Pageof 4

Frequent Collaborators

8 joint publications

Hiroshi Soda

7 joint publications

Shinnosuke Takemoto

7 joint publications

Minoru Fukuda

6 joint publications

Tadaaki Yamada